Myelodysplastic syndrome patients
Number . | Sex . | Race . | Age . | Initial BM diagnosis MDS . | Review BM diagnosis MDS . | Flow bilineage or trilineage dysplasia . | Cytogenetics clonal abnormality . | Final diagnosis . | Erythroid . | Megakaryocytic . | Myeloid . | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Morphology dysplasia . | Flow dysplasia . | Morphology dysplasia . | Flow dysplasia . | Morphology dysplasia . | Flow dysplasia . | |||||||||
1 | F | H | 34 | − | + | + | NE | RA | − (NE) | + | + | − | NE | + |
2 | F | W | 70 | + | + | + | + | RA | + | − | + | + | + | + |
3 | M | W | 60 | + | + | + | − | RA | + | + | + | − | + | + |
4 | M | B | 32 | − | + | + | − | RA | + | + | + | + | + | + |
5 | M | W | 65 | + | + | + | − | RA | + | + | + | − | − | + |
6 | F | W | 72 | − | + | + | + | RA | − | − | + | + | + | + |
7 | F | W | 46 | − | + | − | − | RA | + | − | + | − | + | + |
8 | M | W | 27 | + | + | + | NE | RA | + | + | + | + | + | + |
9 | F | A | 58 | + | + | NE | − | RA | + | + | + | − | + | NE |
10 | F | W | 62 | + | + | + | − | RA | + | + | − | − | + | + |
11 | M | A | 77 | − | + | + | + | RA | + | + | + | + | + | NE |
12 | M | W | 76 | + | + | + | − | RA | + | + | + | − | + | + |
13 | M | B | 61 | + | + | + | + | RA | + | + | + | − | + | + |
14 | F | W | 67 | + | + | + | + | RA | + | + | + | + | − | + |
15 | F | W | 49 | + | + | + | + | RA | − | + | + | + | + | + |
16 | M | W | 60 | − | + | + | + | RA | NE | + | + | + | − | + |
17 | M | W | 69 | + | + | + | − | RA | + | + | + | + | + | + |
18 | M | W | 47 | − | + | − | NE | RA | + | − | + | − | − | + |
19 | F | W | 37 | − | + | + | − | RA | + | + | + | NE | + | + |
20 | F | W | 43 | + | + | + | − | RA | − | + | + | + | + | + |
21 | M | W | 45 | + | + | − | − | RA | + | − | + | − | + | + |
22 | M | W | 56 | + | + | + | − | RA | − | + | + | + | + | + |
23 | M | W | 57 | + | + | + | − | RARS | + | + | + | + | + | + |
24 | M | W | 68 | + | + | + | NE | RARS | + | + | + | + | + | + |
25 | M | W | 72 | + | + | + | + | RARS | + | + | + | + | + | + |
26 | M | W | 60 | + | + | + | + | RARS | + | + | − | + | − | + |
27 | F | W | 66 | + | + | + | + | RARS | + | + | + | − | + | + |
28 | F | W | 44 | − | + | + | − | RARS | + | + | + | + | + | − |
29 | F | W | 67 | + | + | + | + | RARS | + | + | − | + | + | + |
30 | M | W | 61 | − | + | − | NE | RARS | + | − | + | − | NE | + |
31 | M | W | 67 | + | + | + | − | RARS | + | − | + | + | − | + |
32 | M | W | 69 | + | + | + | + | RARS | + | − | + | + | − | + |
33 | M | W | 63 | + | + | + | + | RAEB | − | + | + | + | + | + |
34 | M | W | 64 | − | + | NE | NE | RAEB | − | NE | − | − | + | + |
35 | F | W | 69 | + | + | + | + | RAEB | + | + | + | + | + | + |
36 | F | W | 61 | + | + | + | − | RAEB | + | + | + | − | + | + |
37 | M | W | 65 | + | + | + | + | RAEB | + | + | + | + | + | + |
38 | M | W | 58 | + | + | + | + | RAEB | + | + | + | − | + | + |
39 | M | W | 51 | − | + | − | − | RAEB | + | − | + | − | − | + |
40 | M | W | 81 | + | + | + | + | RAEB | + | + | + | + | + | NE |
41 | M | W | 71 | + | + | + | − | RAEB | − | − | + | + | + | + |
42 | F | W | 61 | + | + | + | + | RAEB | + | + | + | + | + | + |
43 | M | W | 72 | + | + | + | + | RAEB | + | + | + | + | + | + |
44 | M | W | 64 | + | + | + | − | RAEB | + | + | + | − | + | + |
45 | F | W | 63 | + | + | + | + | RAEB-T | + | + | + | − | + | + |
Number . | Sex . | Race . | Age . | Initial BM diagnosis MDS . | Review BM diagnosis MDS . | Flow bilineage or trilineage dysplasia . | Cytogenetics clonal abnormality . | Final diagnosis . | Erythroid . | Megakaryocytic . | Myeloid . | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Morphology dysplasia . | Flow dysplasia . | Morphology dysplasia . | Flow dysplasia . | Morphology dysplasia . | Flow dysplasia . | |||||||||
1 | F | H | 34 | − | + | + | NE | RA | − (NE) | + | + | − | NE | + |
2 | F | W | 70 | + | + | + | + | RA | + | − | + | + | + | + |
3 | M | W | 60 | + | + | + | − | RA | + | + | + | − | + | + |
4 | M | B | 32 | − | + | + | − | RA | + | + | + | + | + | + |
5 | M | W | 65 | + | + | + | − | RA | + | + | + | − | − | + |
6 | F | W | 72 | − | + | + | + | RA | − | − | + | + | + | + |
7 | F | W | 46 | − | + | − | − | RA | + | − | + | − | + | + |
8 | M | W | 27 | + | + | + | NE | RA | + | + | + | + | + | + |
9 | F | A | 58 | + | + | NE | − | RA | + | + | + | − | + | NE |
10 | F | W | 62 | + | + | + | − | RA | + | + | − | − | + | + |
11 | M | A | 77 | − | + | + | + | RA | + | + | + | + | + | NE |
12 | M | W | 76 | + | + | + | − | RA | + | + | + | − | + | + |
13 | M | B | 61 | + | + | + | + | RA | + | + | + | − | + | + |
14 | F | W | 67 | + | + | + | + | RA | + | + | + | + | − | + |
15 | F | W | 49 | + | + | + | + | RA | − | + | + | + | + | + |
16 | M | W | 60 | − | + | + | + | RA | NE | + | + | + | − | + |
17 | M | W | 69 | + | + | + | − | RA | + | + | + | + | + | + |
18 | M | W | 47 | − | + | − | NE | RA | + | − | + | − | − | + |
19 | F | W | 37 | − | + | + | − | RA | + | + | + | NE | + | + |
20 | F | W | 43 | + | + | + | − | RA | − | + | + | + | + | + |
21 | M | W | 45 | + | + | − | − | RA | + | − | + | − | + | + |
22 | M | W | 56 | + | + | + | − | RA | − | + | + | + | + | + |
23 | M | W | 57 | + | + | + | − | RARS | + | + | + | + | + | + |
24 | M | W | 68 | + | + | + | NE | RARS | + | + | + | + | + | + |
25 | M | W | 72 | + | + | + | + | RARS | + | + | + | + | + | + |
26 | M | W | 60 | + | + | + | + | RARS | + | + | − | + | − | + |
27 | F | W | 66 | + | + | + | + | RARS | + | + | + | − | + | + |
28 | F | W | 44 | − | + | + | − | RARS | + | + | + | + | + | − |
29 | F | W | 67 | + | + | + | + | RARS | + | + | − | + | + | + |
30 | M | W | 61 | − | + | − | NE | RARS | + | − | + | − | NE | + |
31 | M | W | 67 | + | + | + | − | RARS | + | − | + | + | − | + |
32 | M | W | 69 | + | + | + | + | RARS | + | − | + | + | − | + |
33 | M | W | 63 | + | + | + | + | RAEB | − | + | + | + | + | + |
34 | M | W | 64 | − | + | NE | NE | RAEB | − | NE | − | − | + | + |
35 | F | W | 69 | + | + | + | + | RAEB | + | + | + | + | + | + |
36 | F | W | 61 | + | + | + | − | RAEB | + | + | + | − | + | + |
37 | M | W | 65 | + | + | + | + | RAEB | + | + | + | + | + | + |
38 | M | W | 58 | + | + | + | + | RAEB | + | + | + | − | + | + |
39 | M | W | 51 | − | + | − | − | RAEB | + | − | + | − | − | + |
40 | M | W | 81 | + | + | + | + | RAEB | + | + | + | + | + | NE |
41 | M | W | 71 | + | + | + | − | RAEB | − | − | + | + | + | + |
42 | F | W | 61 | + | + | + | + | RAEB | + | + | + | + | + | + |
43 | M | W | 72 | + | + | + | + | RAEB | + | + | + | + | + | + |
44 | M | W | 64 | + | + | + | − | RAEB | + | + | + | − | + | + |
45 | F | W | 63 | + | + | + | + | RAEB-T | + | + | + | − | + | + |
BM indicates bone marrow; MDS, myelodysplastic syndrome; H, Hispanic; + or −, whether diagnostic criteria for MDS or dysplasia were met as described in “Patients, materials, and methods” and “Results”; NE, not evaluable; RA, refractory anemia; W, white; B, black; RARS, RA with ringed sideroblasts; RAEB, RA with excess blasts; RAEB-T, RAEB in transformation.